| |

PET/CT Scans May Be Less Accurate in Elderly Mesothelioma Patients

pet/ct scansResearchers at Case Western Reserve are warning cancer doctors not to rely too heavily on PET/CT scans when diagnosing malignant mesothelioma – especially in older patients.

PET/CT is an important tool for staging mesothelioma and can help with diagnosis. But a new case report highlights the problem of false-negative PET/CT scans. 

In this case involving a 77-year-old man, PET/CT showed no mesothelioma. Even the man’s lung fluid tests were negative for mesothelioma. The case is a potent reminder that biopsy is still the gold standard for diagnosing asbestos cancer. 

PET/CT Scans and Other Tools for Diagnosing Mesothelioma

Pleural mesothelioma is a tricky cancer to diagnose. Most patients do not even have symptoms until the disease is in a later stage. If they do have symptoms, they may be vague like coughing or fatigue. 

Doctors use a variety of tools to diagnose mesothelioma. The first one is patient history. Since asbestos is the number one cause of mesothelioma, having a history of asbestos exposure is the first red flag. 

PET/CT scans, MRI images, blood tests, lung fluid tests, and biopsies are other diagnostic tools for mesothelioma. 

PET stands for positron emission tomography. It uses a radioactive tracer to measure the metabolic rate of cells. Cancer cells tend to absorb more of the tracer than normal cells. They show up as bright spots on PET/CT scans. 

The Danger of False Negative Results

The Case Western Reserve University case report shows why it can be dangerous to rely on PET/CT scans for mesothelioma diagnosis. 

The 77-year-old patient had shortness of breath. His doctors found fluid and air in the pleural space around one of his lungs and suspected that he might have cancer. 

They removed some of the fluid and examined it under a microscope. This is a technique that often shows early evidence of mesothelioma. But there were no signs of cancer. 

The man then underwent PET/CT scans with a tracer called FDG. There were still no signs of mesothelioma. It was not until doctors performed a biopsy and looked at the man’s tissue under the microscope that they were able to confirm pleural mesothelioma. 

The team concluded that the man’s age probably affected his metabolic rate. The fact that his tumor was small might also account for the false-positive scan results. The results are similar to those of a 2020 study on PET/CT scans and mesothelioma.

“Older patients with early stage MPM are more likely to have false-negative FDG PET/CT results,” writes author Haley Corbin of Case Western Reserve University School of Medicine. “Pleural biopsy is essential when there is clinical suspicion for mesothelioma, even with negative initial FDG PET imaging.”

About 2,500 Americans receive a diagnosis of mesothelioma each year. The earlier the illness is diagnosed, the better the chances of survival.

Source:

Corbin, H and Packer, C, “False-Negative 18F-Fluorodeoxyglucose PET/CT in Malignant Pleural Mesothelioma”, August 17, 2021, Cureus, Peer Reviewed Case Report, https://www.cureus.com/articles/64800-false-negative-18f-fluorodeoxyglucose-petct-in-malignant-pleural-mesothelioma

 

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • |

    New Prognostic Factor in Peritoneal Mesothelioma

    Malignant peritoneal mesothelioma is a rare form of mesothelioma that attacks the membrane that lines the abdomen and surrounds internal organs. The outlook for this rare malignancy, which affects fewer than 500 Americans annually, has been improved by the treatment combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The combination has produced 5-year overall survival rates ranging from 29% to 63%. But not all peritoneal mesothelioma patients are good candidates for CRS/HIPEC. The challenge, for clinicians, is identifying which patients are likely to benefit from the procedure (or even be cured) and which are not. In an effort to help answer that question, French researchers recently tested the prognostic value of the glucose transporter protein GLUT1 as well as…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

  • | |

    Mesothelioma Surgeons Report New Biopsy Technique

    A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…